Squarex

Squarex is a clinical stage pharmaceutical company located in Mahtomedi, Minnesota. Founded by individuals with backgrounds in Minnesota, Harvard, and Stanford, the company employs a team of three. Squarex specializes in developing pharmaceutical treatments, specifically a topical formulation of squaric acid dibutyl ester, intended for the prevention of recurring cold sores caused by Herpes Simplex Virus 1 or 2. Their focus is on creating a preventative solution for cold sores, aiming to eliminate their recurrence through their product, Squarex. Squarex differentiates itself through its innovative approach to cold sore prevention, leveraging squaric acid dibutyl ester's immunomodulatory properties. Their dedication to bringing this drug to market is evident in their progress through clinical trials. To learn more about Squarex and their advancements, visit their website at squarex-pharma.com.